` S2M (S2Medical AB (publ)) vs OMX Stockholm 30 Comparison - Alpha Spread

S
S2M
vs
O
OMX Stockholm 30

Over the past 12 months, S2M has underperformed OMX Stockholm 30, delivering a return of -70% compared to the OMX Stockholm 30's +4% growth.

Stocks Performance
S2M vs OMX Stockholm 30

Loading
S2M
OMX Stockholm 30
Add Stock
www.alphaspread.com

Performance Gap
S2M vs OMX Stockholm 30

Loading
S2M
OMX Stockholm 30
Difference
www.alphaspread.com

Performance By Year
S2M vs OMX Stockholm 30

Loading
S2M
OMX Stockholm 30
Add Stock

Competitors Performance
S2Medical AB (publ) vs Peers

OMX Stockholm 30
S2M
7741
ALC
COLO B
ALGN
Add Stock

S2Medical AB (publ)
Glance View

Market Cap
10.8m SEK
Industry
Health Care

S2Medical AB engages in research and development in biotechnology. The company is headquartered in Linkoping, Ostergotland. The company went IPO on 2018-11-28. The firm focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The firm's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The firm is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.

S2M Intrinsic Value
0.0308 SEK
Undervaluation 58%
Intrinsic Value
Price
S
Back to Top